Skip to main content
SpringerLink
Log in

Ovary and Peritoneal Washings

  • Chapter
  • First Online:
Practical Cytopathology

Part of the book series: Practical Anatomic Pathology ((PAP))

  • 1178 Accesses

Abstract

This chapter addresses common questions about the cytology of ovarian lesions and technical aspects of ovarian aspiration and peritoneal washings. Aspiration of small ovarian masses and cysts is an uncommon technique used to evaluate adnexal lesions in nonsurgical candidates or grossly benign cysts in women of reproductive age. Primary ovarian lesions are more often sampled by fine-needle aspiration (FNA) and core biopsy in cases of detectable abdominal metastases or pelvic masses of unknown origin. Thus, attention is given to both the clinicopathologic and cytologic features of ovarian lesions. The second part of this chapter will address technical aspects of peritoneal washings, specimens that are routinely obtained in the setting of gynecologic and other abdominal malignancies to exclude occult intraperitoneal disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

AFP:

Alpha-fetoprotein

AGCT:

Adult granulosa cell tumor

AJCC:

American Joint Committee on Cancer

BSO:

Bilateral salpingo-oophorectomy

CEA:

Carcinoembryonic antigen

E2:

Estradiol

ER:

Estrogen receptor

FIGO:

International Federation of Gynecology and Oncologists

FNA:

Fine-needle aspiration

hCG:

Human chorionic gonadotropin

HLM:

Hemosiderin-laden macrophage

IHC:

Immunohistochemistry

JGCT:

Juvenile granulosa cell tumor

PR:

Progesterone receptor

WHO:

World Health Organization

References

  1. Kjellgren O, Angström T, Bergman F, Wiklund DE. Fine-needle aspiration biopsy in diagnosis, and classification of ovarian carcinoma. Cancer. 1971;28(4):967–76. http://www.ncbi.nlm.nih.gov/pubmed/5111748. Accessed 11 Feb 2018.

    Article  CAS  Google Scholar 

  2. Angstrom T, Kjellgren O, Bergman F. The cytologic diagnosis of ovarian tumors by means of aspiration biopsy. Acta Cytol. 1972;16(4):336–41. http://www.ncbi.nlm.nih.gov/pubmed/4504235. Accessed 11 Feb 2018.

    CAS  PubMed  Google Scholar 

  3. Khaw KT, Walker WJ. Ultrasound guided fine needle aspiration of ovarian cysts: diagnosis and treatment in pregnant and non-pregnant women. Clin Radiol. 1990;41(2):105–8. https://doi.org/10.1016/S0009-9260(05)80139-4.

    Article  CAS  PubMed  Google Scholar 

  4. Ateş O, Karakaya E, Hakgüder G, Olguner M, Seçil M, Akgür FM. Laparoscopic excision of a giant ovarian cyst after ultrasound-guided drainage. J Pediatr Surg. 2006;41(10):e9–e11. https://doi.org/10.1016/J.JPEDSURG.2006.06.023.

    Article  PubMed  Google Scholar 

  5. Oleszczuk J, Leszczyńska-Gorzelak B, Kamiński K, Baranowski W. Evaluation of ovarian cysts by means of transabdominal fine needle aspiration or laparotomy in pregnant women. Ginekol Pol. 2002;73(4):367–370. http://www.ncbi.nlm.nih.gov/pubmed/12152287. Accessed 11 Feb 2018.

  6. CRESPIGNY LC, ROBINSON HP, DAVOREN RAM, FORTUNE D. The “simple” ovarian cyst: aspirate or operate? BJOG An Int J Obstet Gynaecol. 1989;96(9):1035–9. https://doi.org/10.1111/j.1471-0528.1989.tb03377.x.

    Article  Google Scholar 

  7. Trimbos JB, Hacker NF. The case against aspirating ovarian cysts. Cancer. 1993;72(3):828–31. https://doi.org/10.1002/1097-0142(19930801)72:3<828::AID-CNCR2820720331>3.0.CO;2-T.

    Article  CAS  PubMed  Google Scholar 

  8. Duke D, Colville J, Keeling A, Broe D, Fotheringham T, Lee MJ. Transvaginal aspiration of ovarian cysts: long-term follow-up. Cardiovasc Intervent Radiol. 2006;29(3):401–5. https://doi.org/10.1007/s00270-005-0167-0.

    Article  CAS  PubMed  Google Scholar 

  9. Koutlaki N, Nikas I, Dimitraki M, et al. Transvaginal aspiration of ovarian cysts: our experience over 121 cases. Minim Invasive Ther Allied Technol. 2011;20(3):155–9. https://doi.org/10.3109/13645706.2010.532220.

    Article  PubMed  Google Scholar 

  10. Nikolaou M, Adonakis G, Zyli P, et al. Transvaginal ultrasound-guided aspiration of benign ovarian cysts. J Obstet Gynaecol (Lahore). 2014;34(4):332–5. https://doi.org/10.3109/01443615.2013.874406.

    Article  CAS  Google Scholar 

  11. Higgins RV, Matkins JF, Marroum M-C. Comparison of fine-needle aspiration cytologic findings of ovarian cysts with ovarian histologic findings. Am J Obstet Gynecol. 1999;180(3):550–3. https://doi.org/10.1016/S0002-9378(99)70252-8.

    Article  CAS  PubMed  Google Scholar 

  12. Bonilla-Musoles F, Ballester MJ, Simon C, Serra V, Raga F. Is avoidance of surgery possible in patients with perimenopausal ovarian tumors using transvaginal ultrasound and duplex color Doppler sonography? J Ultrasound Med. 1993;12(1):33–9. https://doi.org/10.7863/jum.1993.12.1.33.

    Article  CAS  PubMed  Google Scholar 

  13. Geier GR, Strecker JR. Aspiration cytology and E2 content in ovarian tumors. Acta Cytol. 1981;25(4):400–6. http://www.ncbi.nlm.nih.gov/pubmed/6945006. Accessed 11 Feb 2018.

    CAS  PubMed  Google Scholar 

  14. Moran O, Menczer J, Ben-Baruch G, Lipitz S, Goor E. Cytologic examination of ovarian cyst fluid for the distinction between benign and malignant tumors. Obstet Gynecol. 1993;82(3):444–6. http://www.ncbi.nlm.nih.gov/pubmed/8355950. Accessed 11 Feb 2018.

    CAS  PubMed  Google Scholar 

  15. Zhou AG, Levinson KL, Rosenthal DL, VandenBussche CJ. Performance of ovarian cyst fluid fine-needle aspiration cytology. Cancer Cytopathol. 2018;126(2):112–21. https://doi.org/10.1002/cncy.21911.

    Article  PubMed  Google Scholar 

  16. Sevelda P, Dittrich C, Salzer H. Prognostic value of the rupture of the capsule in stage I epithelial ovarian carcinoma. Gynecol Oncol. 1989;35(3):321–2. https://doi.org/10.1016/0090-8258(89)90071-1.

    Article  CAS  PubMed  Google Scholar 

  17. Dembo AJ, Davy M, Stenwig AE, Berle EJ, Bush RS, Kjorstad K. Prognostic factors in patients with stage I epithelial ovarian cancer. Obstet Gynecol. 1990;75(2):263–73. http://www.ncbi.nlm.nih.gov/pubmed/2300355. Accessed 11 Feb 2018.

    CAS  PubMed  Google Scholar 

  18. Trimbos JB, Schueler JA, van Lent M, Hermans J, Fleuren GJ. Reasons for incomplete surgical staging in early ovarian carcinoma. Gynecol Oncol. 1990;37(3):374–7. https://doi.org/10.1016/0090-8258(90)90370-Z.

    Article  CAS  PubMed  Google Scholar 

  19. Sjovall K, Nilsson B, Einhorn N. Different types of rupture of the tumor capsule and the impact on survival in early ovarian carcinoma. Int J Gynecol Cancer. 1994;4(5):333–6. https://doi.org/10.1046/j.1525-1438.1994.04050333.x.

    Article  PubMed  Google Scholar 

  20. Zanetta G, Trio D, Lissoni A, et al. Early and short-term complications after US-guided puncture of gynecologic lesions: evaluation after 1,000 consecutive cases. Radiology. 1993;189(1):161–4. https://doi.org/10.1148/radiology.189.1.8372188.

    Article  CAS  PubMed  Google Scholar 

  21. Livraghi T, Damascelli B, Lombardi C, Spagnoli I. Risk in fine-needle abdominal biopsy. J Clin Ultrasound. 1983;11(2):77–81. https://doi.org/10.1002/jcu.1870110205.

    Article  CAS  PubMed  Google Scholar 

  22. Spanos WJ. Preoperative hormonal therapy of cystic adnexal masses. Am J Obstet Gynecol. 1973;116(4):551–6. https://doi.org/10.1016/0002-9378(73)90913-7.

    Article  CAS  PubMed  Google Scholar 

  23. Brown DL, Doubilet PM, Miller FH, et al. Benign and malignant ovarian masses: selection of the most discriminating gray-scale and Doppler sonographic features. Radiology. 1998;208(1):103–10. https://doi.org/10.1148/radiology.208.1.9646799.

    Article  CAS  PubMed  Google Scholar 

  24. Mulvany N, Ostör A, Teng G. Evaluation of estradiol in aspirated ovarian cystic lesions. Acta Cytol. 1995;39(4):663–8. http://www.ncbi.nlm.nih.gov/pubmed/7631540. Accessed 11 Feb 2018.

    CAS  PubMed  Google Scholar 

  25. Allias F, Chanoz J, Blache G, Thivolet-Bejui F, Vancina S. Value of ultrasound-guided fine-needle aspiration in the management of ovarian and paraovarian cysts. Diagn Cytopathol. 2000;22(2):70–80. https://doi.org/10.1002/(SICI)1097-0339(200002)22:2<70::AID-DC3>3.0.CO;2-J.

    Article  CAS  PubMed  Google Scholar 

  26. Stanley MW, Horwitz CA, Frable WJ. Cellular follicular cyst of the ovary: fluid cytology mimicking malignancy. Diagn Cytopathol. 1991;7(1):48–52. https://doi.org/10.1002/dc.2840070113.

    Article  CAS  PubMed  Google Scholar 

  27. Nuñez C, Diaz JI, Selvaggi S. Ovarian follicular cysts: a potential source of false positive diagnoses in ovarian cytology. Diagn Cytopathol. 1992;8(5):532–7. https://doi.org/10.1002/dc.2840080515.

    Article  PubMed  Google Scholar 

  28. Wojcik EM, Selvaggi SM. Fine-needle aspiration cytology of cystic ovarian lesions. Diagn Cytopathol. 1994;11(1):9–14. https://doi.org/10.1002/dc.2840110104.

    Article  CAS  PubMed  Google Scholar 

  29. Zaloudek CJ, Garg K. Tumors of the female genital tract: ovary, fallopian tube, and broad and round ligaments. In: Fletcher CDM, editor. Diagnostic histopathology of tumors 2. 4th ed. Philadelphia, PA: Elsevier; 2013. p. 658–761.

    Google Scholar 

  30. Nucci M, Oliva E. Diagnostic pathology: gynecological. 1st ed. Philadelphia, PA: Amirsys; 2014.

    Google Scholar 

  31. Kurman R, Carcangiu M, Herrington C, Young R, editors. WHO classification of tumours of female reproductive organs. 4th ed. Lyon: IARC Press; 2014.

    Google Scholar 

  32. Malpica A, Deavers MT, Lu K, et al. Grading ovarian serous carcinoma using a two-tier system. Am J Surg Pathol. 2004;28(4):496–504. http://www.ncbi.nlm.nih.gov/pubmed/15087669. Accessed 21 Feb 2018.

    Article  Google Scholar 

  33. Neely Larry Copeland EJ, Gershenson DM, Taylor Wharton J, Sneige N, Edwards CL, Rutledge FN. Microscopic disease at second-look laparotomy in advanced ovarian cancer. https://onlinelibrary.wiley.com/doi/pdf/10.1002/1097-0142%2819850115%2955%3A2%3C472%3A%3AAID-CNCR2820550231%3E3.0.CO%3B2-A. Accessed 18 Feb 2018.

  34. Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011;474(7353):609–15. https://doi.org/10.1038/nature10166.

    Article  CAS  Google Scholar 

  35. Cole AJ, Dwight T, Gill AJ, et al. Assessing mutant p53 in primary high-grade serous ovarian cancer using immunohistochemistry and massively parallel sequencing. Sci Rep. 2016;6(1):26191. https://doi.org/10.1038/srep26191.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Singer G, Stöhr R, Cope L, et al. Patterns of p53 mutations separate ovarian serous borderline tumors and low- and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis. Am J Surg Pathol. 2005;29(2):218–24. https://doi.org/10.1097/01.pas.0000146025.91953.8d.

    Article  PubMed  Google Scholar 

  37. Okuda T, Otsuka J, Sekizawa A, et al. p53 mutations and overexpression affect prognosis of ovarian endometrioid cancer but not clear cell cancer. Gynecol Oncol. 2003;88(3):318–25. https://doi.org/10.1016/S0090-8258(02)00149-X.

    Article  CAS  PubMed  Google Scholar 

  38. Ho ES, Lai CR, Hsieh YT, et al. p53 mutation is infrequent in clear cell carcinoma of the ovary. Gynecol Oncol. 2001;80(2):189–93. https://doi.org/10.1006/gyno.2000.6025.

    Article  CAS  PubMed  Google Scholar 

  39. Tashiro H, Isacson C, Levine R, Kurman RJ, Cho KR, Hedrick L. p53 gene mutations are common in uterine serous carcinoma and occur early in their pathogenesis. Am J Pathol. 1997;150(1):177–85. http://www.ncbi.nlm.nih.gov/pubmed/9006334. Accessed 18 Feb 2018.

    CAS  PubMed  PubMed Central  Google Scholar 

  40. Lax SF. Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification. Virchows Arch. 2004;444(3):213–23. https://doi.org/10.1007/s00428-003-0947-3.

    Article  CAS  PubMed  Google Scholar 

  41. Fadare O, Gwin K, Desouki MM, et al. The clinicopathologic significance of p53 and BAF-250a (ARID1A) expression in clear cell carcinoma of the endometrium. Mod Pathol. 2013;26(8):1101–10. https://doi.org/10.1038/modpathol.2013.35.

    Article  CAS  PubMed  Google Scholar 

  42. DeLair D, Oliva E, Köbel M, Macias A, Gilks CB, Soslow RA. Morphologic spectrum of immunohistochemically characterized clear cell carcinoma of the ovary. Am J Surg Pathol. 2011;35(1):36–44. https://doi.org/10.1097/PAS.0b013e3181ff400e.

    Article  PubMed  Google Scholar 

  43. Lee KR, Scully RE. Mucinous tumors of the ovary: a clinicopathologic study of 196 borderline tumors (of intestinal type) and carcinomas, including an evaluation of 11 cases with “pseudomyxoma peritonei”. Am J Surg Pathol. 2000;24(11):1447–64. http://www.ncbi.nlm.nih.gov/pubmed/11075847. Accessed 21 Feb 2018.

    Article  CAS  Google Scholar 

  44. Lee KR, Young RH. The distinction between primary and metastatic mucinous carcinomas of the ovary: gross and histologic findings in 50 cases. Am J Surg Pathol. 2003;27(3):281–92. http://www.ncbi.nlm.nih.gov/pubmed/12604884. Accessed 21 Feb 2018.

    Article  Google Scholar 

  45. Vang R, Gown AM, Wu L-S-F, et al. Immunohistochemical expression of CDX2 in primary ovarian mucinous tumors and metastatic mucinous carcinomas involving the ovary: comparison with CK20 and correlation with coordinate expression of CK7. Mod Pathol. 2006;19(11):1421–8. https://doi.org/10.1038/modpathol.3800698.

    Article  CAS  PubMed  Google Scholar 

  46. Moh M, Krings G, Ates D, Aysal A, Kim GE, Rabban JT. SATB2 expression distinguishes ovarian metastases of colorectal and appendiceal origin from primary ovarian tumors of mucinous or endometrioid type. Am J Surg Pathol. 2016;40(3):419–32. https://doi.org/10.1097/PAS.0000000000000553.

    Article  PubMed  Google Scholar 

  47. Shah SP, Köbel M, Senz J, et al. Mutation of FOXL2 in granulosa-cell tumors of the ovary. N Engl J Med. 2009;360(26):2719–29. https://doi.org/10.1056/NEJMoa0902542.

    Article  CAS  PubMed  Google Scholar 

  48. Zhao C, Vinh TN, Mcmanus K, Dabbs D, Barner R, Vang R. Identification of the most sensitive and robust immunohistochemical markers in different categories of ovarian sex cord-stromal tumors. https://insights.ovid.com/pubmed?pmid=19033865. Accessed 1 Feb 2018.

  49. Ramos P, Karnezis AN, Craig DW, et al. Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4. Nat Genet. 2014;46(5):427–9. https://doi.org/10.1038/ng.2928.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. FIGO Committee on Gynecologic Oncology. Current FIGO staging for cancer of the vagina, fallopian tube, ovary, and gestational trophoblastic neoplasia. Int J Gynaecol Obstet. 2009;105(1):3–4. http://www.ncbi.nlm.nih.gov/pubmed/19322933. Accessed 16 Feb 2018.

    Article  Google Scholar 

  51. Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet. 2009;105(2):103–4. http://www.ncbi.nlm.nih.gov/pubmed/19367689. Accessed 16 Feb 2018.

    Article  Google Scholar 

  52. Havrilesky LJ, Cragun JM, Calingaert B, et al. The prognostic significance of positive peritoneal cytology and adnexal/serosal metastasis in stage IIIA endometrial cancer. Gynecol Oncol. 2007;104(2):401–5. https://doi.org/10.1016/j.ygyno.2006.08.027.

    Article  PubMed  Google Scholar 

  53. Sonoda Y, Zerbe M, Smith A, Lin O, Barakat RR, Hoskins WJ. High incidence of positive peritoneal cytology in low-risk endometrial cancer treated by laparoscopically assisted vaginal hysterectomy. Gynecol Oncol. 2001;80(3):378–82. https://doi.org/10.1006/gyno.2000.6079.

    Article  CAS  PubMed  Google Scholar 

  54. Zullo F, Palomba S, Falbo A, et al. Laparoscopic surgery vs laparotomy for early stage endometrial cancer: long-term data of a randomized controlled trial. Am J Obstet Gynecol. 2009;200(3):296.e1–9. https://doi.org/10.1016/j.ajog.2008.10.056.

    Article  Google Scholar 

  55. Prat J. Staging classification for cancer of the ovary, fallopian tube, and peritoneum. Int J Gynecol Obstet. 2014;124(1):1–5. https://doi.org/10.1016/j.ijgo.2013.10.001.

    Article  Google Scholar 

  56. Heintz APM, Odicino F, Maisonneuve P, et al. Carcinoma of the ovary. Int J Gynecol Obstet. 2003;83(S1):135–66. https://doi.org/10.1016/S0020-7292(03)90118-4.

    Article  Google Scholar 

  57. Fadare O, Mariappan MR, Hileeto D, Wang S, McAlpine JN, Rimm DL. Upstaging based solely on positive peritoneal washing does not affect outcome in endometrial cancer. Mod Pathol. 2005;18(5):673–80. https://doi.org/10.1038/modpathol.3800342.

    Article  PubMed  Google Scholar 

  58. Anastasiadis PG, Romanidis KN, Polichronidis A, Koutlaki NG, Tamiolakis D, Simopoulos K. The contribution of rapid intraoperative cytology to the improvement of ovarian cancer staging. Gynecol Oncol. 2002;86(3):244–9. http://www.ncbi.nlm.nih.gov/pubmed/12217743. Accessed 17 Feb 2018.

    Article  CAS  Google Scholar 

  59. Fadare O, Mariappan MR, Wang S, Hileeto D, Mcalpine J, Rimm DL. The histologic subtype of ovarian tumors affects the detection rate by pelvic washings. Cancer. 2004;102(3):150–6. https://doi.org/10.1002/cncr.20239.

    Article  PubMed  Google Scholar 

  60. Bentrem D, Wilton A, Mazumdar M, Brennan M, Coit D. The value of peritoneal cytology as a preoperative predictor in patients with gastric carcinoma undergoing a curative resection. Ann Surg Oncol. 2005;12(5):347–53. https://doi.org/10.1245/ASO.2005.03.065.

    Article  PubMed  Google Scholar 

  61. Kanellos I, Demetriades H, Zintzaras E, Mandrali A, Mantzoros I, Betsis D. Incidence and prognostic value of positive peritoneal cytology in colorectal cancer. Dis Colon Rectum. 2003;46(4):535–9. https://doi.org/10.1007/s10350-004-6595-0.

    Article  CAS  PubMed  Google Scholar 

  62. Yamamoto S, Akasu T, Fujita S, Moriya Y. Long-term prognostic value of conventional peritoneal cytology after curative resection for colorectal carcinoma. Jpn J Clin Oncol. 2003;33(1):33–7. https://doi.org/10.1093/jjco/hyg007.

    Article  PubMed  Google Scholar 

  63. Castillo CF-D, Rattner DW, Warshaw AL. Further experience with laparoscopy and peritoneal cytology in the staging of pancreatic cancer. Br J Surg. 1995;82(8):1127–9. https://doi.org/10.1002/bjs.1800820839.

    Article  Google Scholar 

  64. Makary MA, Warshaw AL, Centeno BA, Willett CG, Rattner DW, Castillo CF. Implications of peritoneal cytology for pancreatic cancer management. Arch Surg. 1998;133(4):361. https://doi.org/10.1001/archsurg.133.4.361.

    Article  CAS  PubMed  Google Scholar 

  65. Pretorius RG, Lee KR, Papillo J, Baker S, Belinson J. False-negative peritoneal cytology in metastatic ovarian carcinoma. Obstet Gynecol. 1986;68(5):619–23. http://www.ncbi.nlm.nih.gov/pubmed/3763072. Accessed 17 Feb 2018.

    CAS  PubMed  Google Scholar 

  66. Cheng L, Wolf NG, Rose PG, Rodriguez M, Abdul-Karim FW. Peritoneal washing cytology of ovarian tumors of low malignant potential: correlation with surface ovarian involvement and peritoneal implants. Acta Cytol. 1998;42(5):1091–4. http://www.ncbi.nlm.nih.gov/pubmed/9755663. Accessed 17 Feb 2018.

    Article  CAS  Google Scholar 

  67. Cibas ES. Peritoneal washings. In: Cibas ES, Ducatman BS, editors. Cytology: diagnostic principles and clinical correlates. 4th ed. Philadelphia, PA: Elsevier; 2014. p. 155–69.

    Google Scholar 

  68. Sneige N, Fernandez T, Copeland LJ, Katz RL. Müllerian inclusions in peritoneal washings. Potential source of error in cytologic diagnosis. Acta Cytol. 1986;30(3):271–6. http://www.ncbi.nlm.nih.gov/pubmed/3012920. Accessed 17 Feb 2018.

    CAS  PubMed  Google Scholar 

  69. Slade AJ, Dieterich M, Sturgis CD. Eosinophilic metaplastic atypia in exfoliated cells of ovarian endometriosis: a potential cytodiagnostic pitfall in peritoneal fluids. Diagn Cytopathol. 2004;31(2):123–5. https://doi.org/10.1002/dc.20031.

    Article  PubMed  Google Scholar 

  70. Sidawy MK, Silverberg SG. Endosalpingiosis in female peritoneal washings: a diagnostic pitfall. Int J Gynecol Pathol. 1987;6(4):340–6. http://www.ncbi.nlm.nih.gov/pubmed/3692676. Accessed 17 Feb 2018.

    Article  CAS  Google Scholar 

  71. Sams VR, Benjamin E, Ward RH. Ectopic pancreas. A cause of false-positive peritoneal cytology. Acta Cytol. 1990;34(5):641–4. http://www.ncbi.nlm.nih.gov/pubmed/2145720. Accessed 17 Feb 2018.

    CAS  PubMed  Google Scholar 

  72. Jacques SM, Selvaggi SM. Multiple peritoneal cytologies collected during laparotomy for gynecologic malignancy. Diagn Cytopathol. 1991;7(5):482–6. https://doi.org/10.1002/dc.2840070509.

    Article  CAS  PubMed  Google Scholar 

  73. Soslow RA. Histologic subtypes of ovarian carcinoma. Int J Gynecol Pathol. 2008;27(2):161–74. https://doi.org/10.1097/PGP.0b013e31815ea812.

    Article  PubMed  Google Scholar 

  74. Zhang Y, Garcia-Buitrago MT, Koru-Sengul T, Schuman S, Ganjei-Azar P. An immunohistochemical panel to distinguish ovarian from uterine serous papillary carcinomas. Int J Gynecol Pathol. 2013;32(5):476–81. https://doi.org/10.1097/PGP.0b013e31826ddc4e.

    Article  CAS  PubMed  Google Scholar 

  75. Kounelis S, Kapranos N, Kouri E, Coppola D, Papadaki H, Jones MW. Immunohistochemical profile of endometrial adenocarcinoma: a study of 61 cases and review of the literature. Mod Pathol. 2000;13(4):379–88. https://doi.org/10.1038/modpathol.3880062.

    Article  CAS  PubMed  Google Scholar 

  76. Yemelyanova A, Vang R, Kshirsagar M, et al. Immunohistochemical staining patterns of p53 can serve as a surrogate marker for TP53 mutations in ovarian carcinoma: an immunohistochemical and nucleotide sequencing analysis. Mod Pathol. 2011;24(9):1248–53. https://doi.org/10.1038/modpathol.2011.85.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, Duke University Medical Center, Durham, NC, USA

    Kyle C. Strickland

Authors
  1. Kyle C. Strickland
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. VA Boston Healthcare System, Boston, MA, USA

    Huihong Xu

  2. Brigham and Women’s Hospital, Boston, MA, USA

    Xiaohua Qian

  3. Robert Wood Johnson University Hospital, New Brunswick, NJ, USA

    He Wang

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Strickland, K.C. (2020). Ovary and Peritoneal Washings. In: Xu, H., Qian, X., Wang, H. (eds) Practical Cytopathology . Practical Anatomic Pathology. Springer, Cham. https://doi.org/10.1007/978-3-030-24059-2_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-24059-2_11

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-24058-5

  • Online ISBN: 978-3-030-24059-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation